We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$56.6B
AUM Growth
+$4.03B
Cap. Flow
+$1.92B
Cap. Flow %
3.4%
Top 10 Hldgs %
7.89%
Holding
3,713
New
414
Increased
1,834
Reduced
1,026
Closed
416

Sector Composition

Rank Sector Weight
1 Technology 15.61%
2 Healthcare 12.42%
3 Financials 11.99%
4 Consumer Staples 9.6%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWR icon
3276
Westwater Resources
WWR
$75.2M
$32K ﹤0.01%
+499
New +$37.2K
AUMN
3277
DELISTED
Golden Minerals Company
AUMN
$32K ﹤0.01%
+1,720
New +$36.6K
VKTX icon
3278
Viking Therapeutics
VKTX
$3.84B
$30K ﹤0.01%
+21,300
New +$28.2K
TLOG
3279
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$30K ﹤0.01%
192,100
-3,000
-2% -$693
TCCO
3280
DELISTED
Technical Communications Corporation
TCCO
$28K ﹤0.01%
10,603
-1,597
-13% -$4.51K
ARMP icon
3281
Armata Pharmaceuticals
ARMP
$177M
$26K ﹤0.01%
121
+6
+5% +$1.38K
CPHI icon
3282
China Pharma Holdings
CPHI
$44.2M
$26K ﹤0.01%
240
+49
+26% +$6.28K
PRZM
3283
DELISTED
Prism Technologies Group, Inc
PRZM
$26K ﹤0.01%
127,200
+19,700
+18% +$4.69K
NOTV
3284
DELISTED
Inotiv
NOTV
$25K ﹤0.01%
21,500
+3,800
+21% +$4.56K
USAU icon
3285
US Gold Corp
USAU
$249M
$25K ﹤0.01%
497
+322
+184% +$18.9K
XTNT icon
3286
Xtant Medical Holdings
XTNT
$43.8M
$25K ﹤0.01%
+1,808
New +$33.3K
NEGG icon
3287
Newegg Commerce
NEGG
$397M
$22K ﹤0.01%
88
-10
-10% -$2.66K
TAIT
3288
DELISTED
Taitron Components
TAIT
$19K ﹤0.01%
16,200
+5,600
+53% +$6.28K
VRDN icon
3289
Viridian Therapeutics
VRDN
$2.49B
$19K ﹤0.01%
168
+100
+147% +$11.2K
CPRX
3290
DELISTED
Catalyst Pharmaceutical
CPRX
$16K ﹤0.01%
+15,000
New +$13.5K
TRX icon
3291
TRX Gold Corp
TRX
$341M
$15K ﹤0.01%
19,200
-74,700
-80% -$76.9K
TEAR
3292
DELISTED
TearLab Corporation
TEAR
$13K ﹤0.01%
+1,980
New +$14.7K
DRYS
3293
DELISTED
DryShips Inc. Common Stock
DRYS
0
UQM
3294
DELISTED
UQM Technologies, Inc.
UQM
$11K ﹤0.01%
17,799
+2,300
+15% +$1.41K
NUWE icon
3295
Nuwellis
NUWE
$474K
0
AGIG
3296
Abundia Global Impact Group
AGIG
$38.5M
$2K ﹤0.01%
102
-639
-86% -$16K
AAP icon
3297
Advance Auto Parts
AAP
$3.46B
-393,150
Closed -$63.5M
AAPL icon
3298
Apple
AAPL
$4.46T
-4,384,132
Closed -$105M
AAT
3299
American Assets Trust
AAT
$1.41B
-30,800
Closed -$1.31M
ACHC icon
3300
Acadia Healthcare
ACHC
$2.82B
-65,315
Closed -$3.62M

Similar funds

Jim Simons's Q3 2016 Portfolio in Review

As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.

  • Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
  • Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
  • Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
  • Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
  • Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
  • Jim Simons opened 414 new positions and closed 416 in Q3 2016.
  • Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.